Antiendothelial cell antibodies: useful markers of systemic sclerosis (Q39448876)

12 September 2017

Antiendothelial cell antibodies: useful markers of systemic sclerosis (English)

1 reference

12 September 2017

1 reference

6

Piette JC

1 reference

12 September 2017

7

Youinou PY

1 reference

12 September 2017

3

Saraux A

1 reference

12 September 2017

Salojin KV

1

1 reference

12 September 2017

Le Tonquèze M

series ordinal

2

1 reference

12 September 2017

Nassonov EL

series ordinal

4

1 reference

12 September 2017

Dueymes M

series ordinal

5

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 February 1997

1 reference

American Journal of Medicine

12 September 2017

1 reference

12 September 2017

102

1 reference

12 September 2017

2

1 reference

12 September 2017

178-185

1 reference

Autoantibody to centromere (kinetochore) in scleroderma sera

12 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900404-4

Markers of endothelial perturbation and damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900404-4

Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900404-4

Endothelial injury in scleroderma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900404-4

Rheumatic disease sera reactive with capillaries in the mouse kidney

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900404-4

Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900404-4

A need for standardization of the anti-endothelial-cell antibody test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900404-4

Permanent cell line expressing human factor VIII-related antigen established by hybridization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900404-4

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900404-4

Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900404-4

Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900404-4

Validity and reliability of three methods used in the diagnosis of Raynaud's phenomenon. The UK Scleroderma Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900404-4

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900404-4

Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900404-4

Systemic involvement and immunologic findings in patients presenting with Raynaud's phenomenon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900404-4

Anticentromere and anticentriole antibodies in the scleroderma spectrum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900404-4

Racial differences in antinuclear antibody patterns and clinical manifestations of scleroderma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900404-4

Racial differences in the frequencies of scleroderma-related autoantibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900404-4

Immunogenetic associations of scleroderma-related antinuclear antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900404-4

Establishment and characterization of permanent human endothelial cell clones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900404-4

Anti-endothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900404-4

Antibodies to endothelial cells in primary vasculitides mediate in vitro endothelial cytotoxicity in the presence of normal peripheral blood mononuclear cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2896%2900404-4

10.1016/S0002-9343(96)00404-4

7 January 2021

Identifiers

DOI

1 reference

12 September 2017

1 reference